News

Technology News

CardioNet Launches Sleep Disorder Clinical Indicator

Friday, May 15, 2009 5:00:00 AM PDT | VentureDeal Staff
Conshohocken, Pennsylvania  --  Medical device company CardioNet (NASDAQ: BEAT) has announced the launch of a new clinical indicator for sleep disorders.

Called the SomNet, the system has the potential to identify patients with a high likelihood of sleep disorders such as sleep apnea by measuring cyclic variation of heart rate.

“There is a high prevalence of sleep disorders like sleep apnea in the cardiovascular and arrhythmia population,” said Randy Thurman, CEO of CardioNet. “The data collected by SomNet is extremely valuable information that can be captured from our existing MCOT ECG signal. If clinically appropriate, physicians may choose to refer patients with CVHR patterns to sleep centers for further diagnostic testing, to determine if they have sleep apnea or another serious sleep disorder.”

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1